{{Drugbox
| IUPAC_name = diethyl [4-(1,3-benzothiazol-2-yl)benzyl]phosphonate
| image = Fostedil_structure.png

<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status = Uncontrolled
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number = 75889-62-2
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 53421
| ChemSpiderID = 48253
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = D41WS786UL
| KEGG = D04260
| ChEMBL = 39516

<!--Chemical data-->
| C=18 | N=1 | O=3 | P=1 | S=1 
| molecular_weight = 361.40 g/mol
| smiles = O=P(OCC)(OCC)Cc3ccc(c1nc2ccccc2s1)cc3
}}

'''Fostedil''' ('''A-53,986''', '''KB-944''') is a [[vasodilator]] acting as a [[calcium channel blocker]] which was under development for the treatment of [[heart disease|heart conditions]] such as [[angina pectoris]] but was never marketed.<ref name="isbn0-412-46630-9">{{cite book | author = David J. Triggle | title = Dictionary of Pharmacological Agents | publisher = Chapman & Hall/CRC | location = Boca Raton | year = 1996 | pages = | isbn = 0-412-46630-9 | oclc = | doi = | url = https://books.google.com/books?id=DeX7jgInYFMC&lpg=PA931&dq=Fostedil&pg=PA931#v=onepage&q}}</ref><ref name="pmid3902675">{{cite journal |vauthors=Khurmi NS, Bowles MJ, O'Hara MJ, Lahiri A, Raftery EB | title = Ambulatory monitoring and exercise testing in the evaluation of a new long-acting calcium ion antagonist KB-944 (Fostedil) for the treatment of exertional angina pectoris | journal = International Journal of Cardiology | volume = 9 | issue = 3 | pages = 289–302 |date=November 1985 | pmid = 3902675 | doi = 10.1016/0167-5273(85)90027-0| url = }}</ref><ref name="pmid6890822">{{cite journal |vauthors=Morita T, Yoshino K, Kanazawa T, Ito K, Nose T | title = Vasodilator action of KB-944, a new calcium antagonist | journal = Arzneimittel-Forschung | volume = 32 | issue = 9 | pages = 1037–42 | year = 1982 | pmid = 6890822 | doi = | url = }}</ref><ref name="pmid6890823">{{cite journal |vauthors=Morita T, Kanazawa T, Ito K, Nose T | title = Vasodilator mechanism of KB-944, a new calcium antagonist | journal = Arzneimittel-Forschung | volume = 32 | issue = 9 | pages = 1043–6 | year = 1982 | pmid = 6890823 | doi = | url = }}</ref> It has [[antihypertensive]] and [[antiarrhythmic]] effects.<ref name="pmid6890824">{{cite journal |vauthors=Morita T, Kanazawa T, Ito K, Nose T | title = Antihypertensive effect of KB-944, a new calcium antagonist, in conscious normotensive and hypertensive rats | journal = Arzneimittel-Forschung | volume = 32 | issue = 9 | pages = 1047–52 | year = 1982 | pmid = 6890824 | doi = | url = }}</ref><ref name="pmid6890825">{{cite journal |vauthors=Morita T, Ito K, Nose T | title = Cardiac action of KB-944, a new calcium antagonist | journal = Arzneimittel-Forschung | volume = 32 | issue = 9 | pages = 1053–5 | year = 1982 | pmid = 6890825 | doi = | url = }}</ref><ref name="pmid6890826">{{cite journal |vauthors=Yoshidomi M, Sukamoto T, Morita T, Ito K, Nose T | title = Antiarrhythmic effect of KB-944, a new calcium antagonist. A comparison with verapamil and diltiazem | journal = Arzneimittel-Forschung | volume = 32 | issue = 9 | pages = 1056–9 | year = 1982 | pmid = 6890826 | doi = | url = }}</ref>

== Synthesis ==

[[Image:Fostedil synthesis.png|700px|center|thumb|Fostedil synthesis:<ref name="pmid3701791">{{Cite journal | doi = 10.1021/jm00155a037| title = Organic phosphorus compounds. 1. 4-(Benzothiazol-2-yl)benzylphosphonate as potent calcium antagonistic vasodilator| journal = Journal of Medicinal Chemistry| volume = 29| issue = 5| pages = 820| year = 1986| last1 = Yoshino | first1 = K. | last2 = Kohno | first2 = T. | last3 = Uno | first3 = T. | last4 = Morita | first4 = T. | last5 = Tsukamoto | first5 = G. }}</ref>]]
#Treatment of benzanilide with [[phosphorus pentasulfide]] or [[Lawesson's reagent]] gives [[thioamide]].
#Oxidative ring formation by reaction with [[potassium ferricyanide]] and base (presumably involving a free radical intermediate) constructs the benzothiazole ring.
#Bromination of this compound with [[N-bromosuccinimide]] produces bromomethyl intermediate.
#The synthesis of fostedil concludes with a [[Michaelis-Arbuzov reaction]] with [[triethyl phosphite]].

== See also ==
*[[Ibrolipim]]
* [[Calcium channel blocker]]

== References ==
{{Reflist}}

{{PAH rx}}
{{Antiarrhythmic agents}}
{{Calcium channel blockers}}

[[Category:Benzothiazoles]]
[[Category:Phosphonate esters]]